62 related articles for article (PubMed ID: 8411732)
41. Trinucleotide repeats in neurologic diseases: an hypothesis concerning the pathogenesis of Huntington's disease, Kennedy's disease, and spinocerebellar ataxia type I.
Cha JH; Dure LS
Life Sci; 1994; 54(20):1459-64. PubMed ID: 8190020
[TBL] [Abstract][Full Text] [Related]
42. Planting alfalfa and cloning the Huntington's disease gene.
Goodfellow PN
Cell; 1993 Mar; 72(6):817-8. PubMed ID: 8458076
[No Abstract] [Full Text] [Related]
43. [Molecular basis of Huntington's disease and possible pathogenic mechanisms].
Martín Aparicio E; Lucas JJ
Rev Neurol; 2002 Aug 1-15; 35(3):212-20. PubMed ID: 12235581
[TBL] [Abstract][Full Text] [Related]
44. Genetics and molecular biology of Huntington's disease.
Albin RL; Tagle DA
Trends Neurosci; 1995 Jan; 18(1):11-4. PubMed ID: 7535483
[TBL] [Abstract][Full Text] [Related]
45. [Huntington disease: disclosing the gene].
Destée A; Chartier-Harlin MC
Presse Med; 1995 Feb; 24(6):312-6. PubMed ID: 7899393
[TBL] [Abstract][Full Text] [Related]
46. Diagnosis of Huntington disease.
Margolis RL; Ross CA
Clin Chem; 2003 Oct; 49(10):1726-32. PubMed ID: 14500613
[TBL] [Abstract][Full Text] [Related]
47. Huntington's disease: recent advances in diagnosis and management.
Furtado S; Suchowersky O
Can J Neurol Sci; 1995 Feb; 22(1):5-12. PubMed ID: 7750074
[TBL] [Abstract][Full Text] [Related]
48. History of genetic disease: the molecular genetics of Huntington disease - a history.
Bates GP
Nat Rev Genet; 2005 Oct; 6(10):766-73. PubMed ID: 16136077
[TBL] [Abstract][Full Text] [Related]
49. Pridopidine for the treatment of Huntington's disease.
Shannon KM
Expert Opin Investig Drugs; 2016; 25(4):485-92. PubMed ID: 26881734
[TBL] [Abstract][Full Text] [Related]
50. [Huntington's disease].
Kodaka F; Itoh T; Kasahara H
Ryoikibetsu Shokogun Shirizu; 2003; (40):261-4. PubMed ID: 14626115
[No Abstract] [Full Text] [Related]
51. Promises and pitfalls of immune-based strategies for Huntington's disease.
Colpo GD; Stimming EF; Rocha NP; Teixeira AL
Neural Regen Res; 2017 Sep; 12(9):1422-1425. PubMed ID: 29089980
[TBL] [Abstract][Full Text] [Related]
52. Proposed genetic basis of Huntington's disease.
Laird CD
Trends Genet; 1990 Aug; 6(8):242-7. PubMed ID: 2146788
[TBL] [Abstract][Full Text] [Related]
53. Why Woody got the blues: The neurobiology of depression in Huntington's disease.
Gubert C; Renoir T; Hannan AJ
Neurobiol Dis; 2020 Aug; 142():104958. PubMed ID: 32526274
[TBL] [Abstract][Full Text] [Related]
54. Recent Advances in the Treatment of Huntington's Disease: Targeting DNA and RNA.
Shannon KM
CNS Drugs; 2020 Mar; 34(3):219-228. PubMed ID: 31933283
[TBL] [Abstract][Full Text] [Related]
55. Specificity of effect in psychiatric research.
Jones MB; Jones DR
Can J Psychiatry; 1992 Feb; 37(1):40-5. PubMed ID: 1532339
[TBL] [Abstract][Full Text] [Related]
56. Management of Agitation in Huntington's Disease: A Review of the Literature.
Rossi G; Oh JC
Cureus; 2020 Aug; 12(8):e9748. PubMed ID: 32944463
[TBL] [Abstract][Full Text] [Related]
57. Huntington's disease: nearly four decades of human molecular genetics.
Gusella JF; Lee JM; MacDonald ME
Hum Mol Genet; 2021 Oct; 30(R2):R254-R263. PubMed ID: 34169318
[TBL] [Abstract][Full Text] [Related]
58. [Huntington's disease--advances in gene mapping].
Nakamura S
Nihon Rinsho; 1993 Sep; 51(9):2481-7. PubMed ID: 8411732
[TBL] [Abstract][Full Text] [Related]
59. [From gene to disease; HD gene and Huntington disease].
Maat-Kievit JA; Losekoot M; Roos RA
Ned Tijdschr Geneeskd; 2001 Nov; 145(44):2120-3. PubMed ID: 11723754
[TBL] [Abstract][Full Text] [Related]
60. Huntington's disease: clinical presentation and treatment.
Novak MJ; Tabrizi SJ
Int Rev Neurobiol; 2011; 98():297-323. PubMed ID: 21907093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
